{"disease":{"id":"patients-with-leptomeningeal-disease","name":"patients with leptomeningeal disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03091478","title":"Pembrolizumab in Patients With Leptomeningeal Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}